CTOs on the Move

Ovid Therapeutics

www.ovidrx.com

 
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ovidrx.com
  • 1460 Broadway
    New York, NY USA 10036
  • Phone: 646.661.7661

Executives

Name Title Contact Details
Stephanie Licata
VP, Program Leadership & Portfolio Management Profile

Funding

Ovid Therapeutics raised $75M on 08/11/2015
Ovid Therapeutics raised $25.86M on 01/23/2017
Ovid Therapeutics raised $25M on 02/26/2019
Ovid Therapeutics raised $20M on 02/26/2019

Similar Companies

UltraRAD Corp

UltraRAD Corp is a West Berlin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care Rx Corporate Office

Care Rx Corporate Office is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BroMenn Healthcare System

BroMenn Healthcare System is a Normal, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Varian

Varian Medical Systems` vision is a world without fear of cancer. To meet this challenge, we equip the world with new tools for fighting cancer. Since the 1950s we have been producing tools that harness the power of X-ray energy to benefit humankind. Our history is one of pioneering developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. Today, we have a robust product portfolio and long-standing relationships with many of the world`s leading clinicians. As Varian continues to grow, our staff of over 6,500 people in 70 sales and support offices around the globe is developing innovative, cost-effective solutions that help make the world a healthier place. Varian reserves the right to remove any comment for any reason and ban any user from its page at is sole discretion. Varian does not endorse user comments on its page and cannot confirm their accuracy. User comments do not necessarily represent the ideas, thoughts, beliefs, opinions or views of Varian, or any of its affiliates.

Dark Heart Nursery

Since 2007, Dark Heart Nursery has specialized in cultivating high quality clones for growers across Northern California.   Our years of experience allow us to bring you consistently premium clones from both popular and emerging genetic lines that will perform well in a variety of settings. We take pride in our work and continually adapt our process and selection to meet the diverse needs of growers large and small.